ATE260665T1 - Derivate des erythromycins, des clarithromycins, des roxithromycins oder des azithromycin mit antibiotischer und mucolytischer wirkung - Google Patents
Derivate des erythromycins, des clarithromycins, des roxithromycins oder des azithromycin mit antibiotischer und mucolytischer wirkungInfo
- Publication number
- ATE260665T1 ATE260665T1 AT99947823T AT99947823T ATE260665T1 AT E260665 T1 ATE260665 T1 AT E260665T1 AT 99947823 T AT99947823 T AT 99947823T AT 99947823 T AT99947823 T AT 99947823T AT E260665 T1 ATE260665 T1 AT E260665T1
- Authority
- AT
- Austria
- Prior art keywords
- antibiotic
- mucolytic
- roxithromycin
- clarithromycin
- azithromycin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE980869 | 1998-10-20 | ||
IE981062 | 1998-12-17 | ||
PCT/IE1999/000106 WO2000023081A1 (en) | 1998-10-20 | 1999-10-15 | Derivatives of erythromycin, clarithromycin, roxithromycin or azithromycin with antibiotic and mucolytic activity |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE260665T1 true ATE260665T1 (de) | 2004-03-15 |
Family
ID=26320218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99947823T ATE260665T1 (de) | 1998-10-20 | 1999-10-15 | Derivate des erythromycins, des clarithromycins, des roxithromycins oder des azithromycin mit antibiotischer und mucolytischer wirkung |
Country Status (7)
Country | Link |
---|---|
US (1) | US6599885B2 (de) |
EP (1) | EP1121134B1 (de) |
AT (1) | ATE260665T1 (de) |
AU (1) | AU760884B2 (de) |
CA (1) | CA2346870A1 (de) |
DE (1) | DE69915327T2 (de) |
WO (1) | WO2000023081A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2403757A1 (en) * | 2000-03-28 | 2001-10-04 | Biochemie Gesellschaft M.B.H. | Granulated particles with masked taste |
WO2007008537A2 (en) * | 2005-07-07 | 2007-01-18 | Elan Pharma International, Limited | Nanoparticulate clarithromycin formulations |
WO2010014306A1 (en) * | 2008-07-28 | 2010-02-04 | Tyco Healthcare Group Lp | Antimicrobial and anticoagulant compositions and methods |
BR112012014926A2 (pt) * | 2009-12-18 | 2015-09-15 | Univ Northwest | composição compreendendo uma forma vítrea não cristalina e amorfa de azitromicina |
CN104177457A (zh) * | 2013-05-23 | 2014-12-03 | 长春海悦药业有限公司 | 一种阿奇霉素药物原料及其制剂和用途 |
US11744859B2 (en) | 2017-07-07 | 2023-09-05 | Epicentrx, Inc. | Compositions and methods for parenteral administration of therapeutic agents |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2824443A1 (de) | 1978-06-03 | 1979-12-13 | Basf Ag | Lagerstabile und fliessfaehige silikatsuspensionen |
IT1134457B (it) * | 1980-11-26 | 1986-08-13 | Real Sas Di Alberto Reiner | Derivato dell'alfa-mercapto propionilglicina ad attivita' terapeutica,procedimento per la sua preparazione e relative composizioni farmaceutiche |
IT1134458B (it) * | 1980-11-26 | 1986-08-13 | Real Sas Di Alberto Reiner | Derivato della n-acetil-cisteina ad attivita' terapeutica,procedimento per la sua preparazione e relative composizioni farmaceutiche |
FR2519988B1 (fr) * | 1982-01-20 | 1985-06-14 | Refarmed Sa | Derives thioliques de l'erythromycine a activite therapeutique, procede de preparation et produits pharmaceutiques dans lesquels ils apparaissent |
FR2502627A1 (fr) | 1981-02-02 | 1982-10-01 | Refarmed Sa | Derives thioliques de l'erythromycine a activite therapeutique, procede de preparation et produits pharmaceutiques dans lesquels ils apparaissent |
IT1189285B (it) * | 1982-05-28 | 1988-02-04 | Nuovo Consor Sanitar Nazionale | Sali dell'antibiotico eritromicina e del suo estere propionico con acidi ad attivita' terapeutica coadiuvante |
AU4399396A (en) * | 1994-12-19 | 1996-07-10 | Russinsky Limited | Compounds |
AU3861497A (en) * | 1996-08-07 | 1998-02-25 | Russinsky Limited | Process for the production of salts of erythromycin, roxithromycin, clarithromycin and azithromycin |
-
1999
- 1999-10-15 AT AT99947823T patent/ATE260665T1/de not_active IP Right Cessation
- 1999-10-15 DE DE69915327T patent/DE69915327T2/de not_active Expired - Fee Related
- 1999-10-15 WO PCT/IE1999/000106 patent/WO2000023081A1/en active IP Right Grant
- 1999-10-15 EP EP99947823A patent/EP1121134B1/de not_active Expired - Lifetime
- 1999-10-15 AU AU61185/99A patent/AU760884B2/en not_active Ceased
- 1999-10-15 CA CA002346870A patent/CA2346870A1/en not_active Abandoned
-
2001
- 2001-04-19 US US09/837,416 patent/US6599885B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69915327T2 (de) | 2005-02-10 |
EP1121134A1 (de) | 2001-08-08 |
CA2346870A1 (en) | 2000-04-27 |
DE69915327D1 (de) | 2004-04-08 |
AU760884B2 (en) | 2003-05-22 |
EP1121134B1 (de) | 2004-03-03 |
WO2000023081A1 (en) | 2000-04-27 |
US6599885B2 (en) | 2003-07-29 |
US20010031736A1 (en) | 2001-10-18 |
AU6118599A (en) | 2000-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL166527A0 (en) | Macrolide compounds endowed with antiinflammatory activity | |
WO2003004509A3 (en) | C12 modified erythromycin macrolides and ketolides having antibacterial activity | |
BR9502016A (pt) | Derivado de propiofenona processo para a preparação do mesmo composição farmacêutica agente antidiabete e uso do dito derivado | |
AU2002239841A1 (en) | Proteoglycan compositions for treatment of inflammatory conditions | |
NZ335825A (en) | Use of azithromycin for treating atherosclerosis | |
DK1112005T3 (da) | Antioxiderende præparat, som omfatter acetyl-L-carnitin og alfa-lipoinsyre | |
EA200000594A1 (ru) | Новые макролиды | |
ATE260665T1 (de) | Derivate des erythromycins, des clarithromycins, des roxithromycins oder des azithromycin mit antibiotischer und mucolytischer wirkung | |
DK1216256T3 (da) | Makrolid-antibiotika og behandling af pasteurellosis | |
NO20012272D0 (no) | Nye erythromycinderivater, fremstillingsmetode og anvendelse som medisiner | |
DE60303967D1 (de) | 9a-azalide mit entzündungshemmender wirkung | |
NO20012464D0 (no) | 13-leddete azalider og deres anvendelse som antibiotiske midler | |
NO20001439D0 (no) | 3'-N-modifiserte 6-O-substituerte erytromycin ketolid- derivater med antibakteriell aktivitet | |
EA200501552A1 (ru) | Фармацевтические композиции с менее выраженным горьким вкусом | |
WO1996000576A3 (de) | Neue klinische anwendungen von polyen-makroliden | |
BR0015780A (pt) | Processo para preparar claritromicina | |
ATE261425T1 (de) | Erythromycin-derivate mit antibiotischer wirkung | |
WO2002042315A3 (en) | Macrolide solvates | |
HK1064607A1 (en) | Use of sucralfate for the preparation of medicament of cervical erosion treatment | |
DE69923835D1 (de) | Makrolid-lhrh-antagonisten | |
BR0207061A (pt) | Composição e método para o tratamento de lúpus e de doenças inflamatórias das articulações | |
MX9606111A (es) | Antibioticos macrolidos. | |
AR011105A1 (es) | Formulacion de liposoma parenteral que reduce el dolor | |
NO950143L (no) | Derivater av antibiotiske makrolider med 16-leddet ring | |
Hlasta et al. | Ketolide antibacterials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |